A norbornyl route to cyclohexitols: Structural diversity in fragmentation through functional group switching. Synthesis of α- and β- galactose, α-talose and α-fucopyranose carbasugars

Article abstract of DOI:10.1016/S0040-4039(00)00408-1

A novel fragmentation sequence has been executed within the norbornane system, involving C₁-C₇ bond scission, to extract a versatile, highly functionalized cyclohexanoid moiety. Its further evolution towards a range-of carbasugars is described. (C) 2000 Elsevier Science Ltd.

Full text of DOI:10.1016/S0040-4039(00)00408-1

TETRAHEDRON
LETTERS
Pergamon
Tetrahedron Letters 41 (2000) 3505–3508
A norbornyl route to cyclohexitols: structural diversity in
fragmentation through functional group switching. Synthesis of
α- and β-galactose, α-talose and α-fucopyranose carbasugars
Goverdhan Mehta,∗ Narinder Mohal and Sripada Lakshminath
Department of Organic Chemistry, Indian Institute of Science, Bangalore 560 012, India
Received 14 February 2000; accepted 7 March 2000
Abstract
A novel fragmentation sequence has been executed within the norbornane system, involving C1–C7 bond
scission, to extract a versatile, highly functionalized cyclohexanoid moiety. Its further evolution towards a range of
carbasugars is described. © 2000 Elsevier Science Ltd. All rights reserved.
Keywords: fragmentation reactions; carbasugars; hydroxylation.
There is a great deal of current interest in cyclitols, the polyhydroxylated cyclohexanoids, as these
structural entities not only constitute important segments of a diverse range of natural products, e.g.
antibiotics, but also exhibit promising biological activity profiles ranging from glycosidase inhibitors
to antidiabetes and anticancer agents.1 Some of the better known examples of cyclohexitols of natural
occurrence are the carbasugars, e.g. pseudo-α-galactose 1, condutriols, e.g. condutriol-A 2, inositols,
e.g. myo-inositol 1,4,5-triphosphate 3 and gabosines, e.g. gabosine-C 4, displaying dense and stereo-
chemically varied oxygenation patterns on the six-membered ring. Not surprisingly, the cyclohexitols
have attracted the widespread attention of synthetic chemists.2 Among the main synthetic strategies
that have been explored in this context are: (i) restructuring of carbohydrates to carbocycles;3 (ii)
aromatics to carbasugars via either the microbially produced cis-cyclohexadiene diols2b,4a or 1,4-
cyclohexadienylsilanes;4b (iii) [4+2]-cycloaddition chemistry based on α-pyrone and 1,3-butadiene
derivatives;5 (iv) 7-oxabicyclo[2.2.1]heptanes as ‘naked sugars’;6 and (v) 7-keto-norbornyl systems as
cyclohexanoid equivalents.7
∗
Corresponding author. E-mail: gm@orgchem.iisc.ernet.in (G. Mehta)
0040-4039/00/$ - see front matter © 2000 Elsevier Science Ltd. All rights reserved.
PII: S0040-4039(00)00408-1
tetl 16688

3506
Recently, we have delineated a new and fairly general approach to cyclopentitols, based on the bi-
cyclo[2.2.1]heptane (norbornane) framework, in which the inherent stereo- and regioselective preferences
of the norbornyl system are fully exploited.8 The main feature of this approach was the setting up of
a Grob-like ‘bottom-to-top’ fragmentation process in a suitably crafted 2,7-disubstituted norbornane
derivative 5 to cleave the C1–C2 bond 6, and extraction of the five-membered ring 7 from the bridged
bicyclic frame with full functionalization, Scheme 1.
Scheme 1.
We have now envisioned a new fragmentation process in the norbornyl system by switching func-
tionalities in 5 to 8, to orchestrate a ‘top-to-bottom’ sequence through C7–C1 bond cleavage (see 9) to
deliver a functionally embellished cyclohexanoid 10 in a regio- and stereoselective manner, Scheme
2. Implementation of this theme, leading to the stereoselective syntheses of diverse cyclohexitols,
particularly several carbasugars is reported here.
Scheme 2.
In order to execute Scheme 2, easy access to a precursor corresponding to 8 was required and this
was accomplished as shown in Scheme 3. Bicyclic alcohol 11,7,8 readily available from 5,5-dimethoxy-
1,2,3,4-tetrachlorocyclopentadiene and vinyl acetate, was tosylated and subjected to OsO4-mediated
catalytic dihydroxylation to furnish exo,exo-diol 12.9 It is interesting to note that despite considerable
steric hindrance on the exo- as well as the endo-face, the norbornene double bond in 11 is smoothly and
stereoselectively dihydroxylated in keeping with our earlier observations on this system.7,8 Amberlyst
mediated single-pot protection–deprotection in 12 led to the desired 7-norbornanone derivative 13.9
Exposure of 13 to NaOMe resulted in a smooth ‘top-to-bottom’ fragmentation (see, Scheme 2) to furnish
the cyclohexene methyl ester 149 as a single product. In the cyclohexenoid 14 of secured stereochemistry,
five ring carbons had substitution pattern well poised for further elaboration to carbasugars.
Scheme 3. Reagents and conditions: (a) i. TsCl, Py, DMAP, DCM, rt, 90%; ii. OsO4, NMMO, Me2CO:H2O (4:1), rt, 2 days,
84%; (b) Amberlyst-15, aq. Me2CO, rt, 90%; (c) NaOMe, MeOH, rt, 3 h, 70%
Osmylation of cyclohexenoid ester 14 proceeded in a stereoselective manner from the face opposite
to the acetonide and ester moieties to furnish cis-diol 159 in excellent yield, Scheme 4. LAH reduction
of the ester group and acetonide deprotection furnished the naturally occurring carbasugar pseudo-α-
galactose 1,10 which is conveniently characterised as its penta-acetate 16.9 Alternately, the ester group

3507
in 14 was reduced with LAH and acetylated to give 17.9 Epoxidation of 17 proceeded stereoselectively
from the less hindered α-face to deliver 18.9 Acid catalysed epoxide ring opening and concomitant
acetonide deprotection furnished a (5:2:3) mixture of pseudo-β-galactose 19a, pseudo-α-talose 20a and
the bicyclic ether 21a, which were best separated and characterised as the corresponding acetates 19b,9
20b9 and 21b,9 respectively, Scheme 4.
Scheme 4. Reagents and conditions: (a) OsO4, NMMO, 30 h, 95%; (b) i. LAH, THF, rt, 88%; ii. Amberlyst-15, aq. MeOH, 3 h;
iii. Ac2O, Py, 20 h, 74% (two steps); (c) i. LAH, THF, 0–5°C, 1 h, 90%; ii. Ac2O, DMAP, DCM, 95%; (d) MCPBA, Na2CO3,
DCM, 6 h, 65%; (e) i. cat. HClO4(70%), H2O, 30 h; ii. Ac2O, Py, 67% (two steps)
Lastly, ester 14 was elaborated into pseudo-α-fucopyranose 22, a carbasugar that has evoked much
attention due to its possible application as an inhibitor of fucosyltransferases. Four syntheses of 22
have been reported in literature in recent years11 but our synthetic approach is notable for its brevity
and stereoselectivity. The diol ester 15 obtained from 14 was transformed into the bis-acetonide and
subjected to LAH reduction to give 23.9 Tosylation of 23 followed by reductive detosylation employing
sodium borohydride in DMSO led to the installation of the β-methyl group and bis-acetonide 249 was
realised quite conveniently, Scheme 5. Deprotection in 24 delivered pseudo-α-fucopyranose 22, whose
spectroscopic characteristics were identical to those reported in the literature.9,11
Scheme 5. Reagents and conditions: (a) i. Me2CO, Amberlyst-15, mol. sieves 4 Å, rt, 1 h, 85%; ii. LAH, THF, 0°C, 2 h, 82%;
(b) i. TsCl, Py, DCM, rt, 94%; ii. NaBH4, DMSO, 70°C, 6 h, 72%; (c) Amberlyst-15, aq. MeOH, rt, 10 h, 75%
In short, we have disclosed here a new and versatile approach towards carbasugars from a readily
accessible 2,7-disubstituted norbornane precursor, involving a novel ‘top-to-bottom’ Grob-like frag-
mentation as the pivotal step. In the accompanying letter, we demonstrate the general utility of the
polyhydroxylated cyclohexenoid synthesis developed here. An interesting aspect of our effort is that
both 5 and 13, precursors of cyclopentitols and cyclohexitols, respectively, are obtained from the same
starting material 11. Thus, by simply interchanging functional groups (see 5 and 13), it is possible to
extract either five- or six-membered ring from the norbornyl system.

3508
Acknowledgements
N.M. and S.L. thank CSIR for the award of Research Fellowships. Part of this work was carried out at
the University of Hyderabad.
References
1. Reviews: (a) Heightman, T. D.; Vasella, A. T. Angew. Chem., Int. Ed. Engl. 1999, 38, 750. (b) Jacob, G. S. Curr. Opin.
Struct. Biol. 1995, 5, 605. (c) Suami, T.; Ogawa, S. Adv. Carbohydr. Chem. Biochem. 1990, 48, 21. (d) Suami, T. Top. Curr.
Chem. 1990, 154, 257.
2. (a) Balci, M.; Sutbeyaz, Y.; Secen, H. Tetrahedron 1990, 46, 3715. (b) Hudlicky, T.; Entwistle, D. A.; Pitzer, K. K.; Thorpe,
A. J. Chem. Rev. 1996, 96, 1195 and references cited therein. (c) Suami, T. Pure Appl. Chem. 1987, 59, 1509.
3. (a) Martinez-Grau, A.; Marco-Contelles, J. Chem. Soc. Rev. 1998, 27, 155. (b) Sudha, A. V. R. L.; Nagarajan, M. J. Chem.
Soc., Chem. Commun. 1998, 925 and references cited therein.
4. (a) Pingli, L.; Vandewalle, M. Synlett 1994, 228. (b) Landais, Y. Chimia, 1998, 52, 104.
5. Afarinkia, K.; Mahmood, F. Tetrahedron 1999, 55, 3129 and earlier references cited therein.
6. (a) Ogawa, S.; Iwasawa, Y.; Nose, T.; Suami, T.; Ohba, S.; ItSaito, Y. J. Chem. Soc., Perkin Trans. 1 1985, 903. (b) Ogawa,
S.; Ara, M.; Kondoh, T.; Saitoh, M.; Masuda, R.; Tokokuni, T.; Suami, T. Bull. Chem. Soc. Jpn. 1980, 53, 1121. (c)
Takahaski, T.; Kotsubo, H.; Iyobe, A.; Namiki, T.; Koizumi, T. J. Chem. Soc., Perkin Trans. 1 1990, 3065. (d) Acena, J. L.;
Arjona, O.; Fernandez de la Pradilla, R.; Plumet, J.; Viso, A. J. Org. Chem. 1994, 59, 6419.
7. (a) Mehta, G.; Mohal, N. Tetrahedron Lett. 1998, 39, 3285. (b) Mehta, G.; Mohal, N. Tetrahedron Lett. 1998, 39, 3281.
8. (a) Mehta, G.; Mohal, N. Tetrahedron Lett. 1999, 40, 5791. (b) Mehta, G.; Mohal, N. Tetrahedron Lett. 1999, 40, 5795.
9. All new compounds reported here were racemic and characterized on the basis of spectroscopic data and elemental analyses.
Selected spectroscopic data (J in Hz). 14: δH (200 MHz, CDCl3): 5.83 (1H, ddd, J 10, 6, 2), 5.66–5.58 (1H, m), 4.72–4.69
(1H, m), 4.62–4.59 (1H, m), 3.75 (3H, s), 2.75 (1H, ddd, J 11.5, 5.5, 2), 2.6–2.41 (1H, m), 2.29–2.14 (1H, m), 1.37 (6H,
s); δC (50 MHz, CDCl3): 172.52, 127.85, 126.53, 109.45, 73.01 (2C), 52.01, 42.04, 27.64, 26.85, 21.22. 16: δH (300 MHz,
CDCl3): 5.57 (1H, dd as t, J 2.5), 5.50 (1H, dd as q, J 3), 5.20 (2H, dABq, J 11, 3), 4.01–3.85 (2H, m), 2.5–2.45 (1H, m),
2.11 (6H, s), 2.03 (3H, s), 2.0 (3H, s), 1.99 (3H, s), 1.79–1.75 (2H, m); δC (50 MHz, CDCl3): 170.51, 170.03 (2C), 169.83
(2C), 69.65, 69.38, 68.35 (2C), 62.93, 33.31, 26.71, 20.84, 20.56 (4C). 19b: δH (300 MHz, CDCl3): 5.49 (1H, br s), 5.39
(1H, dd as t, J 10), 4.97–4.89 (1H, m), 4.89 (1H, dd, J 10.5, 3), 4.0 (1H, dd, J 11, 9), 3.87 (1H, dd, J 11, 6), 2.25–2.13 (1H,
m), 2.13 (3H, s), 2.04 (6H, s), 2.03 (3H, s), 2.03–1.95 (1H, m), 1.98 (3H, s), 1.70–1.58 (1H, m); δC (75 MHz, CDCl3):
170.66, 170.10, 170.02 (2C), 169.9, 72.0, 71.29, 70.77, 67.53, 62.72, 34.71, 27.09, 20.85, 20.68 (3C), 20.55. 20b: δH (300
MHz, CDCl3): 5.40 (1H, dd as t, J 3), 5.21 (1H, dd as t, J 3.5), 5.18–5.11 (2H, m), 4.10 (1H, dd, J 11, 8), 3.97 (1H, dd,
J 11, 6.5), 2.44–2.41 (1H, m), 2.10 (3H, s), 2.09 (6H, s), 2.05 (3H, s), 2.02 (3H, s), 2.01–1.92 (1H, m), 1.71–1.65 (1H,
m); δC (75 MHz, CDCl3): 170.80, 169.91, 169.79, 169.45, 169.36, 68.55 (2C), 68.38, 67.34, 62.97, 33.71, 24.00, 21.01,
20.70 (4C). 21b: δH (200 MHz, CDCl3): 5.19 (1H, d, J 6), 5.12 (1H, dd, J 6, 3), 4.89 (1H, br d, J 4), 4.32 (1H, d, J 9.5),
4.30 (1H, d, J 8.5), 3.73 (1H, dd, J 8.5, 4), 2.51 (1H, m), 2.13 (3H, s), 2.08 (3H, s), 2.01 (3H, s), 1.98–1.91 (2H, m); δC
(50 MHz, CDCl3): 169.67, 169.53, 168.81, 73.51, 72.58, 69.16 (2C), 67.93, 38.77, 31.16, 20.77, 20.67 (2C). 22: δH (200
MHz, CD3OD): 3.93 (1H, dd, J 6, 3), 3.73 (1H, br s), 3.7–3.55 (2H, m), 2.09–1.93 (1H, m), 1.62–1.45 (2H, m), 0.97 (3H,
d, J 7); δC (50 MHz, CD3OD): 75.48, 73.45, 72.71, 70.93, 34.30, 30.35, 17.68.
10. Miller, T. W.; Arison, B. H.; Albers-Schonberg, G. Biotechnol. Bioeng. 1973, 15, 1075.
11. (a) Tran, C. H.; Crout, D. H. G. Tetrahedron: Asymmetry 1996, 7, 2403. (b) Carless, H. A. J.; Malik, S. S. J. Chem. Soc.,
Chem. Commun. 1995, 2447. (c) Redlich, H.; Sudau, W.; Szardenings, A. K.; Vollerthun, R. Carbohydrate Res. 1992, 226,
57. (d) Cai, S.; Stroud, M. R.; Hakomori, S.; Toyokuni, T. J. Org. Chem. 1992, 57, 6693.